A19. Attachment 2 - List of Products.docx

This is a List of Products attachment outlining the vaccine items eligible for procurement under the FY26-27 Adult Covid-19 Vaccines solicitation. The document specifies three vaccine products, each identified by product/brand name and National Drug Code (NDC) number, though the specific product names and NDC numbers are redacted in the provided version. These products represent the approved vaccines that offerors may supply under the resulting Indefinite Delivery/Indefinite Quantity (ID/IQ) contract awarded by the Centers for Disease Control and Prevention (CDC).

The vaccines listed will be procured to support the CDC's Section 317 immunization program, which provides vaccines to state and local health departments for adult populations at greatest risk for under-vaccination. The contract covers vaccine procurement for both the 2026-2027 and 2025-2026 seasons, with the primary focus on the 2026-2027 season. Awardees include the fifty state health departments, several large city health programs, and U.S. Territories, who may purchase vaccines using federal Section 317 funds as well as state and local funds.